Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor.
about
Mutational analysis of the conserved basic domain of human immunodeficiency virus tat proteinInteractions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivatorThe human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for functionA novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteinsRegulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cellsPresence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat).A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.Multifaceted activities of the HIV-1 transactivator of transcription, Tat.Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.Tat-independent replication of human immunodeficiency viruses.Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein.Structure of simian immunodeficiency virus regulatory genesRapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines.Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1Effect on HIV-1 gene expression, Tat-Vpr interaction and cell apoptosis by natural variants of HIV-1 Tat exon 1 and Vpr from Northern IndiaEfficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure.Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques.The rev-responsive element negatively regulates human immunodeficiency virus type 1 env mRNA expression in primate cells.HIV-1 Tat protein promotes formation of more-processive elongation complexes.HIV-1, reactive oxygen species, and vascular complicationsPresence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.Endothelial cells and cathepsins: Biochemical and biomechanical regulation.Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells.Simian immunodeficiency virus displays complex patterns of RNA splicing.Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins.Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein.Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.Preventive effect of ascorbic acid against biological function of human immunodeficiency virus trans-activator of transcriptionTemporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expressionHIV-1 Tat mediates degradation of RON receptor tyrosine kinase, a regulator of inflammation.Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers.Genetic regulation of human immunodeficiency virus.Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes.Depletion of hnRNP A2/B1 overrides the nuclear retention of the HIV-1 genomic RNA.The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA
P2860
Q24656004-BC8CEBBD-D06F-4F8C-AA21-890812204659Q24671522-35000DBA-6ACC-4B45-93BD-CA0F778DF1E3Q24682531-A9D8FDC2-3AC4-494A-B890-D9B07F4AE537Q28246228-876C7D70-CBC2-4F09-86EE-330E1131C842Q28339853-739A3691-3300-4888-BEAA-945AF444199BQ30450216-C6ECC92A-DC08-4B0D-8CBE-8697AF4B977CQ33192810-95C785DC-1469-451C-9F3B-F23D2934B5CBQ33662926-BDD21A24-E474-4A53-95F1-BAEEEE991CA0Q33743566-6B2A7713-02FA-4508-9B38-9D4D60F02310Q33799971-A35C6408-B701-4628-8B6C-4A3A97D57103Q33924816-FC974112-FF29-4C65-B660-8DCECB0799E8Q34195783-64168C43-628C-485D-8CF1-430AA7F656EAQ34220747-2FEBE88B-0A3E-4BF4-B88A-900553DE7E1BQ34284560-982DD2D1-AE39-44DD-8642-DDCBEE26B7D2Q34304672-F4C35808-B4D8-43F0-B51E-D23E074B163BQ34306796-1EAC7987-E170-46A0-9AA9-1770DDA13ED8Q35075250-A7E3C6B3-D5C4-44BC-811F-C65298980966Q35835407-AB2D395C-154A-4FA1-8769-791041F8A8E0Q35857581-6EF9989E-C8D5-4D98-AE0A-99A416B4F2EDQ35867631-E3C221BA-6894-41B2-AEBC-1CD78EA1BD62Q35937536-C90F41B1-AA1C-4168-98A0-739EFAB796E3Q36040759-06086EC3-6855-49AD-AA94-C5CF3E0A0202Q36554054-DAD6BD7C-1CA5-49A6-B512-73030C3419CDQ36563605-960D0E18-C12E-435B-B963-D61F823412D6Q36654112-ABC35C8B-AA30-4957-9DDC-9B5671584B4EQ36782518-45AC5BCF-7105-4A41-8478-3CC37A58E82DQ36782740-F902F8FA-9DCE-4F30-B167-72463CD6A6CCQ36783395-56FC5E8D-0D28-4C1D-A481-CFA1EBEAD1B0Q36803520-5BE96ACC-4462-4073-82B3-BF44ABB38226Q36804564-C872BD77-DE58-425D-9EDE-46AAD1A78225Q36806618-1968D13E-4FB0-49C8-8C9F-F37BD937CC02Q36810554-2E18B806-ABEE-4D7C-A433-EB4DB7BB4C0CQ36810917-52CB35E4-3385-4755-9723-C17BCF3788B8Q36830303-3F51F92A-C765-4581-8B0E-7CE239E84993Q36877203-3055C385-52FD-466A-A4AD-21953AB0D38FQ36932902-4A90671B-6DC5-460B-BAD6-E2B043D7C4C3Q37056955-235BBF68-5866-4042-BEBA-FB14DA452D39Q37528880-94D008A2-7DE2-41EA-96C9-091F6EA4C4CDQ37534394-2C40106B-973A-4122-A404-749A79CB9DC0Q37548928-A98BA439-8665-409D-AD0F-880121BA4AC4
P2860
Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor.
description
1988 nî lūn-bûn
@nan
1988 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Missense mutations in an infec ...... on of the rev splice acceptor.
@ast
Missense mutations in an infec ...... on of the rev splice acceptor.
@en
type
label
Missense mutations in an infec ...... on of the rev splice acceptor.
@ast
Missense mutations in an infec ...... on of the rev splice acceptor.
@en
prefLabel
Missense mutations in an infec ...... on of the rev splice acceptor.
@ast
Missense mutations in an infec ...... on of the rev splice acceptor.
@en
P2093
P2860
P356
P1476
Missense mutations in an infec ...... on of the rev splice acceptor.
@en
P2093
P2860
P304
P356
10.1073/PNAS.85.23.9224
P407
P577
1988-12-01T00:00:00Z